Profile
Sector:
HealthcareIndustry:
Medical Care FacilitiesCountry:
United StatesIPO:
04 June 2020Website:
http://theoncologyinstitute.comNext earnings report:
08 August 2024Last dividends:
N/ANext dividends:
N/APrice
after hours | Fri, 05 Jul 2024 21:17:54 GMTDividend
Analysts recommendations
Institutional Ownership
TOI Latest News
The Oncology Institute, Inc. (NASDAQ: TOI) Q1 2024 Earnings Conference Call on May 14, 2024 at 5:00 PM ET with Company Participants Dan Virnich, CEO, and Mihir Shah, CFO. Conference Call Participants include Jack Slevin from Jefferies. The operator welcomes everyone to the call, which is being recorded.
The Oncology Institute, Inc. (TOI) reported a quarterly loss of $0.22 per share, which was higher than the Zacks Consensus Estimate of a loss of $0.12 per share. This is an increase from the loss of $0.10 per share reported a year ago.
The Oncology Institute (TOI) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
The Oncology Institute, Inc. (NASDAQ:TOI ) Q3 2023 Earnings Conference Call November 8, 2023 5:00 PM ET Company Participants Mark Hueppelsheuser - General Counsel Dan Virnich - Chief Executive Officer Mihir Shah - Chief Financial Officer Conference Call Participants Jack Slevin - Jefferies Operator Good afternoon, and welcome to The Oncology Institute Third Quarter 2023 earnings conference call. Today's call is being recorded, and we have allocated one hour for prepared remarks and Q&A.
CERRITOS, Calif., Oct. 18, 2023 (GLOBE NEWSWIRE) -- The Oncology Institute, LLC (“TOI”) (NASDAQ: TOI), one of the largest value-based oncology groups in the United States, today announced that the company will release its third quarter 2023 financial results after the market close on Wednesday, November 8, 2023, to be followed by a conference call the same day at 5:00 p.m. (Eastern Time).
The Oncology Institute, Inc. (NASDAQ:TOI ) Q2 2023 Earnings Conference Call August 8, 2023 5:00 PM ET Company Participants Mark Hueppelsheuser - General Counsel Dan Virnich - Chief Executive Officer Mihir Shah - Chief Financial Officer Conference Call Participants Taji Phillips - Jefferies Operator Good afternoon ladies and gentlemen and welcome to The Oncology Institute's Second Quarter 2023 Earnings Conference Call. Today's call is being recorded and we have allocated one hour for prepared remarks and Q&A.
CERRITOS, Calif., July 18, 2023 (GLOBE NEWSWIRE) -- The Oncology Institute, LLC (“TOI”) (NASDAQ: TOI) one of the largest value-based oncology groups in the United States, today announced that the company will release its second quarter 2023 financial results after the market close on Tuesday, August 8, 2023, to be followed by a conference call the same day at 5:00 p.m. (Eastern Time).
What type of business is Oncology Institute?
The Oncology Institute, Inc., an oncology company, provides medical oncology services in the United States. Its services include physician services, in-house infusion and dispensary, clinical trial services, radiation, outpatient stem cell transplants and transfusions programs, and patient support. The company also offers and manages clinical trial services, such as managing clinical trials, palliative care programs, and stem cell transplants services. It serves adult and senior cancer patients. The company operates 67 clinic locations. The Oncology Institute, Inc. was founded in 2007 and is based in Cerritos, California.
What sector is Oncology Institute in?
Oncology Institute is in the Healthcare sector
What industry is Oncology Institute in?
Oncology Institute is in the Medical Care Facilities industry
What country is Oncology Institute from?
Oncology Institute is headquartered in United States
When did Oncology Institute go public?
Oncology Institute initial public offering (IPO) was on 04 June 2020
What is Oncology Institute website?
https://theoncologyinstitute.com
Is Oncology Institute in the S&P 500?
No, Oncology Institute is not included in the S&P 500 index
Is Oncology Institute in the NASDAQ 100?
No, Oncology Institute is not included in the NASDAQ 100 index
Is Oncology Institute in the Dow Jones?
No, Oncology Institute is not included in the Dow Jones index
When does Oncology Institute report earnings?
The next expected earnings date for Oncology Institute is 08 August 2024